Oppenheimer Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Buy
12,072
+3,015
+33% +$429K 0.02% 660
2025
Q4
$1.51M Buy
9,057
+3,813
+73% +$638K 0.02% 577
2025
Q3
$1.03M Sell
5,244
-10,235
-66% -$1.68M 0.01% 749
2025
Q2
$1.4M Sell
15,479
-516
-3% -$40.8K 0.02% 674
2025
Q1
$954K Buy
15,995
+6,783
+74% +$627K 0.01% 727
2024
Q4
$1.22M Sell
9,212
-5,125
-36% -$481K 0.01% 669
2024
Q3
$751K Buy
+14,337
New +$673K 0.01% 792

Other funds holding ALAB

Oppenheimer Asset Management's ALAB Position: Q1 2026 in Review

Oppenheimer Asset Management increased its Astera Labs (ALAB) stake by 33% in Q1 2026, buying an estimated $429K and bringing the position to 12,072 shares worth $1.32M. The position accounts for 0.02% of the portfolio, ranked #660.

Oppenheimer Asset Management first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.51M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Oppenheimer Asset Management held 12,072 shares of Astera Labs worth $1.32M as of Q1 2026.
  • Oppenheimer Asset Management bought 3,015 Astera Labs shares in Q1 2026, an estimated $429K.
  • Astera Labs made up 0.02% of Oppenheimer Asset Management's portfolio in Q1 2026, its #660 holding.
  • Oppenheimer Asset Management first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • Oppenheimer Asset Management's Astera Labs position peaked at $1.51M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.